{{Rsnum
|rsid=8
|Gene=CDK6
|Chromosome=7
|position=92779015
|Orientation=plus
|GMAF=0.08678
|Gene_s=CDK6
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 69.6 | 26.8 | 3.6
| HCB | 99.3 | 0.7 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 94.7 | 5.3 | 0.0
| CHB | 99.3 | 0.7 | 0.0
| CHD | 99.1 | 0.9 | 0.0
| GIH | 93.1 | 5.9 | 1.0
| LWK | 98.2 | 1.8 | 0.0
| MEX | 70.7 | 27.6 | 1.7
| MKK | 98.7 | 1.3 | 0.0
| TSI | 66.3 | 32.7 | 1.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22761665
|Title=A Novel, Non-Apoptotic Role for Scythe/BAT3: A Functional Switch between the Pro- and Anti-Proliferative Roles of p21 during the Cell Cycle
|OA=1
}}

{{PMID Auto
|PMID=18174243
|Title=Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population.
|OA=1
}}

{{PMID Auto
|PMID=19543528
|Title=Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}